INNOVAGE HOLDING CORP. FILES (8-K) Disclosing Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits

Item 5.02 Departure of Directors or Principal Officers; Election of Directors;

          Appointment of Principal Officers

On June 30, 2022, InnovAge Holding Corp. (the "Company") announced that James G.
Carlson had joined the Company's Board of Directors as Chairman of the Board and
a member of the Compensation, Nominating and Governance Committee. Mr. Carlson will serve as a Class II director until the Company's Annual Meeting of
Shareholders to be held in fiscal year 2023, and until such time as his
successor is duly elected and qualified, or until his earlier death, resignation
or removal.

Mr. Carlson served as director of Omnicare Inc. (NYSE:OCR) from 2013 through
2015 when the company was acquired by CVS Pharmacy, Inc. Prior to that, he was
the Chief Executive Officer, President and Chairman of the Board of Amerigroup
Corp., a multi-state managed healthcare company, from September 2007 through
December 2012, retiring after Amerigroup merged with WellPoint Inc. (now known
as Anthem, Inc.). He was Amerigroup's President and Chief Operating Officer from
2003 to 2007. Prior to that, he was Executive Vice President of UnitedHealth
Group and President of its UnitedHealthcare business unit, which served more
than ten million members in HMO and PPO plans nationwide. Mr. Carlson's diverse
experience also includes over 17 years with Prudential Financial, Inc. Mr. Carlson is a member of the boards of PurFoods LLC, a home meal delivery
service, and is co-founder of Guidon Partners. Mr. Carlson attended Morningside
University and graduated from from Rider University.

In connection with his appointment, Mr. Carlson received a grant of restricted
stock units with a grant date fair value of $125,000, vesting in full on the
first anniversary of the grant date, subject to Mr. Carlson's continued service
on the Board through such vesting date. Additionally, Mr. Carlson will be
entitled to receive: (i) a cash retainer in the amount of $100,000 per year in
respect of his service as a member of the Board and its committee(s) and (ii) an
additional cash retainer in the amount of $100,000 per year in respect of his
service as Chairman of the Board. The Company will also enter into its standard
form of indemnification agreement with Mr. Carlson the form of which was filed
as Exhibit 10.2 to the Company's Registration Statement filed with the
Securities and Exchange Commission on Form S-1 on February 8, 2021.

The Company is not aware of any related party transactions or relationships
between Mr. Carlson and the Company that would require disclosure under Item
404(a) of Regulation S-K. Mr. Carlson was selected as a director pursuant to the
Director Nomination Agreement, dated March 8, 2021, by and between the Company
and the entities affiliated with Apax Partners and Welsh, Carson, Anderson &
Stowe, the Company's principal shareholders.

Item7.01 Regulation FD Disclosure

On June 30, 2022, the Company issued a press release announcing the appointment
of Mr. Carlson to the Board. A copy of the press release is furnished as
Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 7.01, including Exhibit 99.1, is being furnished
and shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to
the liabilities of that section, nor shall such information be deemed
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

The following exhibits are filed or furnished as part of this Report:

Exhibit#   Description
  99.1       Press Release of InnovAge Holding Corp., dated June 30, 2022
104        Cover Page Interactive Data file (formatted as Inline XBRL)